Search results for "Highlights"


 
Results 1 - 10 of about 369 for "Highlights".

From Annals of Internal Medicine

Ten studies from 2013 with potential to change endocrinology practice were summarized in Annals of Internal Medicine's annual Update in Endocrinology, published in the June 3 issue.
June 2014

ACP Diabetes Monthly

HIGHLIGHTS. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus feugiat dui non mattis aliquam.

Highlights

The American Diabetes Association made recommendations on diagnosing and treating heart failure in patients with diabetes, and a study found increased risk of progression to clinical heart failure in those with an HbA1c level of 7% or above.
June 2022

Highlights

The biomarker may be useful for predicting this condition, especially in areas that don't have access to retinal imaging, according to an analysis of ophthalmology patients in the United Kingdom and India.
May 2022

Highlights

Patients with diabetes and chronic kidney disease often had discordance between their HbA1c levels and continuous glucose monitoring (CGM) data, with the HbA1c being significantly higher on average than the CGM-calculated glucose, a French study
May 2022

Keeping tabs

These results demonstrate within- and between-class differences, highlight the drawbacks of a binary interpretation of the results, particularly in the context of the current designs of noninferiority trials, and have
May 2022

Highlights

A systematic review and meta-analysis of 76 randomized trials found that use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with increased risk of gallbladder or biliary diseases, especially when used at higher doses, for longer
April 2022

Highlights

An industry-funded case-control study of data from a U.S. administrative claims database found that pregnancy, alcohol misuse, short or rapid-acting insulin, and smoking, among other conditions and medications, were independently associated with
April 2022

Highlights

A retrospective study of patients who took sodium-glucose cotransporter-2 (SGLT-2) inhibitors or metformin as first-line therapy for type 2 diabetes found similar risk for myocardial infarction and stroke with the two drug classes but a difference
June 2022

Highlights

Diet as a primary intervention can achieve remission for many with type 2 diabetes and should focus on plant-based foods with minimal consumption of meat and other animal products, according to a statement from the American College of Lifestyle
June 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next